Search Results Search Sort by RelevanceMost Recent Case and Commentary Aug 2003 Palliative Care for an Infant with Short Bowel Syndrome and Advanced Liver Disease, Commentary 2 Roytesa Savage, MD, Ronald M. Perkin, MD, MA, and Joseph R. Zanga, MD Several physicians offer commentary on when it may be ethical to choose to not pursue life-prolonging treatments for terminally ill infants. Virtual Mentor. 2003;5(8):315-318. doi: 10.1001/virtualmentor.2003.5.8.ccas4-0308. Case and Commentary Aug 2003 Palliative Care for an Infant with Short Bowel Syndrome and Advanced Liver Disease, Commentary 1 Mark Sheldon, PhD Several physicians offer commentary on when it may be ethical to choose to not pursue life-prolonging treatments for terminally ill infants. Virtual Mentor. 2003;5(8):312-314. doi: 10.1001/virtualmentor.2003.5.8.ccas4-0308. In the Literature Aug 2003 The Pediatrician's Role in Family Decision Making Susanna Smith The American Academy of Pediatrics Task Force on the Family recommends that pediatricians take a more active role in helping to insure that the family environment is conducive to a child's emotional and physical well-being. Virtual Mentor. 2003;5(8):322-324. doi: 10.1001/virtualmentor.2003.5.8.jdsc2-0308. Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580. Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. Pagination First page « First Previous page ‹ Previous … Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Next page Next › Last page Last »
Case and Commentary Aug 2003 Palliative Care for an Infant with Short Bowel Syndrome and Advanced Liver Disease, Commentary 2 Roytesa Savage, MD, Ronald M. Perkin, MD, MA, and Joseph R. Zanga, MD Several physicians offer commentary on when it may be ethical to choose to not pursue life-prolonging treatments for terminally ill infants. Virtual Mentor. 2003;5(8):315-318. doi: 10.1001/virtualmentor.2003.5.8.ccas4-0308.
Case and Commentary Aug 2003 Palliative Care for an Infant with Short Bowel Syndrome and Advanced Liver Disease, Commentary 1 Mark Sheldon, PhD Several physicians offer commentary on when it may be ethical to choose to not pursue life-prolonging treatments for terminally ill infants. Virtual Mentor. 2003;5(8):312-314. doi: 10.1001/virtualmentor.2003.5.8.ccas4-0308.
In the Literature Aug 2003 The Pediatrician's Role in Family Decision Making Susanna Smith The American Academy of Pediatrics Task Force on the Family recommends that pediatricians take a more active role in helping to insure that the family environment is conducive to a child's emotional and physical well-being. Virtual Mentor. 2003;5(8):322-324. doi: 10.1001/virtualmentor.2003.5.8.jdsc2-0308.
Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.
Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.